BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) on the Verge of Changing History with Berubicin
Feb 4, 2021
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, has set sights on an encouraging future for glioblastoma patients with its upcoming Phase 2 trial of Berubicin. The article detailing this groundbreaking news quoted the company’s CEO John Climaco as saying, “Anthracyclines as a class of chemotherapy have been used for over 60 years to treat a variety of cancers… However, historically, anthracyclines have never been used to treat primary or metastatic brain cancers because scientists could not demonstrate that anthracyclines were able to cross the blood-brain barrier and achieve significant levels of activity in the brain. Berubicin may change that history because it is the first anthracycline that, based on limited clinical data, appears to cross the blood-brain barrier and achieve drug levels critical for efficacy against central nervous system malignancies.” This is welcome news for glioblastoma patients, given that they “have a median survival rate of 14.6 months from the date of the malignancy’s diagnosis.” Berubicin was the focus of another company’s Phase 1 testing, conducted in 2006 with 25 participants. “11 of them (44%) achieved ‘statistically significant improvement in clinical benefit,’ and one of them continued to survive completely cancer-free as of last February 20.”
To view the full article, visit https://ibn.fm/66LB9
About CNS Pharmaceuticals Inc.
CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. For more information, visit the company’s website at www.CNSPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Public Colleges Are Passing the $50,000-a-Year Mark. For Locals.
At the University of California campuses in Berkeley, Irvine and Santa Barbara, students get an unwitting education in navigating the housing market.
100 million import orders? Yiwu did it in a flash!
China's Yiwu has just hit 100 million import orders for 2026, a full 40 days earlier than the previous year. The world's wholesale market is now the world's shopping cart!
Global funding for nature still falling short: Paulson Institute
Global funding for nature still falling short: Paulson Institute
Budget to include £1bn for social and affordable housing
The move will take funding for the 10-year programme to more than £40bn.
Schroders: China's capital market opening deepens two-way connectivity
China's capital market opening-up is a very positive long-term development that deepens two-way connectivity between China and international capital markets, said Yu Xueyu, CEO of Schroders Hong Kong, in an interview with CGTN.
My Co-Worker Is Losing It Over My Religion
Plus: Reader responses to a woman returning to the office after two decades of self-employment.
The Long Life of the ‘Snacking Occasion’
As eating habits shift, the food industry is promoting any opportunity to nibble.
China's industrial growth gains momentum
China's industrial growth gains momentum. Strong growth in AI-related manufacturing, emerging industries and equipment investment highlights the country's new development drivers.
Expert: China's AI infra sector offers investment opportunities
As China advances the development of new quality productive forces during the 15th Five-Year Plan period (2026–2030), Tan Poh Hwee, president of the Asia Academy of Digital Economics, told CGTN that China has already built strong momentum in these fields.
Rosebank: Life on the oil field at the centre of a political storm
Scotland editor James Cook finds out what life is like on board a ship in an untapped oil field awaiting its fate.
Heating oil costs 'more than double' ahead of winter
Middleton in Teesdale has no mains gas supply so many residents use expensive heating oil.
UAE's Ras Al Khaimah signs friendship agreement with Fujian Province
One of the key outcomes of Ras Al Khaimah Ruler H.H. Sheikh Saud bin Saqr Al Qasimi's visit to China is a paper to formalize the sisterhood agreement between Ras Al Khaimah and Fujian Province.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.